2026 Conference Claim Ledger

Purpose

Freeze the substantive intervention claims made in Fanti's 2026 EFCAP and EAPL keynote descriptions before reverse-mapping them to peer-reviewed evidence. This ledger is the evidentiary target; supporting papers must match intervention, population, comparator, endpoint, and follow-up rather than merely resemble the claim.

Source A — EFCAP 2026 keynote

Title: Technology-Supported Interventions Targeting Aggression and Antisocial Behavior Official source: https://cyprusconferences.org/efcap2026/keynote-speakers/

ID	Intervention family	Conference-level claim	Claimed endpoint class	Evidence required to substantiate at same strength
EFCAP-01	Computerized attention modification	Training shifts attention toward positive/emotional stimuli and is linked to reductions in anger, antisocial behavior, and psychopathic traits.	attentional + behavioral/trait	Peer-reviewed intervention study with relevant training, comparator, antisocial/anger/psychopathy endpoint, and clear pre/post or longitudinal effect.
EFCAP-02	VR mindfulness + executive functioning	VR-based intervention enhances empathy and reduces anger, aggression, and hostility.	empathy + aggression/hostility	Peer-reviewed VR intervention study identifying immersive modality, sample, comparator, and distal behavioral outcomes.
EFCAP-03	HRV biofeedback	HRV biofeedback improves emotion regulation and reduces CU traits.	physiological/regulatory + trait	Peer-reviewed biofeedback intervention showing actual HRV training, relevant comparator, emotion-regulation measure, and CU outcome.
EFCAP-04	Non-invasive brain stimulation	Brain stimulation improves emotion recognition and is associated with reductions in symptoms related to ASPD.	emotion-recognition + symptom	Peer-reviewed stimulation study with appropriate symptom measure and evidence of symptom change, not only emotion-recognition change.

Source B — EAPL 2026 keynote

Title: Neuroscience-Informed, Technology-Enhanced Interventions for Antisocial Behavior and Emotional Disorders Official source: https://eapl2026.com/keynote-lectures/

ID	Intervention family	Conference-level claim	Claimed endpoint class	Evidence required to substantiate at same strength
EAPL-01	Computerized cognitive modification	Training shifts attention toward positive/emotional stimuli and produces reductions in anger, antisocial behavior, anxiety, and psychopathic traits.	attentional + symptom + behavioral/trait	Peer-reviewed controlled intervention evidence for each endpoint or clearly separated studies supporting the composite claim.
EAPL-02	VR mindfulness + executive functioning	VR intervention enhances empathy and reduces hostility, aggression, anxiety, and depression symptoms.	empathy + behavioral + emotional symptoms	Peer-reviewed VR intervention evidence with modality, comparator, sample, and distal outcomes specified.
EAPL-03	HRV biofeedback	Biofeedback improves emotion regulation and decreases CU traits.	regulatory + trait	Peer-reviewed HRV-biofeedback intervention evidence with CU and emotion-regulation endpoints.
EAPL-04	Non-invasive brain stimulation	Stimulation improves emotion recognition and reduces symptoms associated with ASPD.	proximal mechanism + symptom	Evidence must distinguish emotion-recognition improvement from actual ASPD-symptom reduction.
EAPL-05	Combined TMS + cognitive modification	Combined intervention yields additional decreases in anxiety.	self-reported/clinical symptom	AUDIT: `tension` (v0.3.2). The best-matching 2025 randomized feasibility study directly tested added benefit and did not show superior anxiety reduction from active cTBS + AMT versus sham cTBS + AMT. Proximal attention/gaze effects were supported. See Audit-EAPL-05-TMS-AMT-Anxiety.

EAPL-05 audit result

The 2025 randomized feasibility study of active cTBS + AMT reports that the combined active treatment was not superior to sham cTBS + active AMT for reducing self-reported anxiety symptoms, although attentional and gaze outcomes changed. The first-priority audit is complete. The peer-reviewed trial does not substantiate incremental anxiety reduction from the combined active treatment. A targeted search did not identify a separate peer-reviewed Fanti-led study that supplies that missing incremental effect. The claim therefore remains a tension unless unpublished or later evidence is identified.

Primary paper: Sikki M, Konikkou K, Konstantinou N, Fanti KA. Experimental Brain Research (2025). DOI: 10.1007/s00221-025-07040-9.

Audit statuses

unmapped — no underlying paper identified.
candidate-match — plausible paper found; endpoint/population/comparator not yet fully matched.
matched-proximal — supports a proximal mechanism but not the conference-level distal claim.
matched-partial — supports some, but not all, elements of the claim.
matched-full — peer-reviewed evidence matches intervention, population, comparator, endpoint and relevant follow-up.
tension — available evidence materially qualifies or conflicts with the conference wording.
conference-only — no peer-reviewed outcome evidence located after systematic search.

v0.3.3 update — EFCAP-01 / EAPL-01 identity audit

The phrase computerized cognitive modification is now treated as a conference-level umbrella, not one intervention. At least three distinct Fanti-linked lineages are publicly identifiable: GENAMAT AMT/cTBS+AMT, standalone ABM/eye-tracking, and hostile-attribution-bias modification; a fourth 2026 'combined ABM' community study remains identity-incomplete. See Audit-EFCAP01-EAPL01-Cognitive-Modification-Identity and Attention-Cognitive-Modification-Evidence-Map.

Current status:

positive/emotional attention: matched-proximal via the 2025 GENAMAT RCT;
anxiety: matched-partial/tension because AMT-related anxiety change is present but active cTBS did not add superiority;
anger: conference-only/unmapped-to-peer-reviewed-outcome;
antisocial behavior: unmapped-to-peer-reviewed-outcome;
psychopathic traits: unmapped-to-peer-reviewed-outcome.

v0.3.4 update — endpoint provenance audit

A systematic public-source search did not recover results-bearing abstracts or peer-reviewed outcome papers for the four EFCAP 2026 cognitive-modification presentations. The conference programme establishes that these studies occurred and identifies the constructs they targeted, but it does not establish outcome direction or effect magnitude.

Revised EFCAP-01 / EAPL-01 endpoint status:

attention/gaze change — matched-proximal;
anxiety — matched-partial/tension;
anger — conference-only; provenance unresolved;
antisocial behavior — conference-only; source study unidentified;
psychopathic traits — conference-only; source study unidentified;
aggression and emotion regulation in HAB work — conference-targeted; effect unverified;
angry rumination — conference-targeted; effect direction unverified.

Construct warning: narcissism in one HAB presentation cannot be substituted for psychopathic traits in the keynote claim.

v0.3.5 HRV claim resolution

HRV-01 — improved emotion regulation

EFCAP wording: HRV biofeedback associated with improved emotion regulation.
EAPL wording: studies reveal improvements in emotion regulation.
Evidence status: supported with qualification by Petridou dissertation physiological outcomes and author interpretation; broad distal clinical emotion-regulation efficacy and durability remain unestablished.
Anchor: Claim-HRV-Emotion-Regulation

HRV-02 — decreases/reductions in CU traits

EFCAP/EAPL wording: reductions/decreases in callous-unemotional traits.
Evidence status: unresolved. Petridou dissertation uses CU traits as a differentiating/moderating construct and does not provide a located direct pre/post CU-trait reduction result.
Anchor: Claim-HRV-CU-Reduction

v0.3.6 VR provenance audit

EFCAP-02 / EAPL-02 — VR mindfulness + executive functioning

Programmatic VR involvement: verified.
Fanti-linked VR measurement/elicitation work: peer reviewed, but not treatment efficacy.
University of Cyprus multimodal VR infrastructure: verified capability, not efficacy evidence.
Fanti role as Arche XR Research Scientist: verified translational-network link.
Impact VR peer-reviewed RCTs: adjacent ecosystem evidence for CU traits, conduct problems, reactive aggression, emotion recognition, relationships and social stress; Fanti is not an author on the located efficacy papers.
Exact Fanti/DPL mindfulness + executive-function VR protocol: not publicly identified.
Keynote endpoints empathy / anger / hostility / anxiety / depression: exact provenance unresolved.
Keynote aggression endpoint: adjacent-support only via Impact VR reactive-aggression result; not attributable to Fanti without explicit contribution evidence.

Current status: programmatically-supported / exact-efficacy-provenance-unresolved. See Audit-VR-Intervention-Provenance-v0.3.6 and Claim-VR-Composite-Keynote-2026.

v0.3.7 brain-stimulation claim resolution

EFCAP-04 / EAPL-04 — emotion recognition + APD/ASPD symptom reduction

Emotion-recognition improvement: matched-proximal / fulltext-verified via Konikkou, Kostantinou & Fanti (2020).
APD relevance: supported-with-qualification; effect concentrated in a group elevated on baseline ASRI-4 APD symptoms, not a clinically diagnosed ASPD sample.
APD/ASPD symptom reduction: not demonstrated in located Fanti-led evidence; APD symptoms were not remeasured post-stimulation in the 2020 study.
Later 2025 cTBS evidence: strengthens emotional-attention/mechanism branch but does not provide an APD/ASPD symptom endpoint.
Overall status: tension / matched-proximal.

See Audit-Brain-Stimulation-ASPD-v0.3.7 and Claim-Brain-Stimulation-ASPD-Symptom-Reduction.